Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Statement of Cash Flows [Abstract]
Net income	$ 28,198	$ 18,694
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	5,737	2,339
ESOP and stock compensation expense	3,188	2,437
Depreciation	2,421	2,710
Amortization of premiums and deferred loan costs, net of accretion of discounts and deferred loan fees	3,580	754
Amortization of debt issuance costs	168	167
Amortization of intangible assets	35	64
Amortization of operating lease right-of-use assets	3,565	3,486
Income on bank-owned life insurance	(5,238)	(2,939)
Net gain on sale of loans	0	(51)
Proceeds from sale of loans held-for-sale	0	673
Origination of loans held-for-sale	0	(622)
Losses on available-for-sale debt securities, net	0	6
Gains on trading securities, net	(1,513)	(1,597)
Net sales of trading securities	429	387
Increase in accrued interest receivable	(333)	(808)
Increase in other assets	(2,021)	(8,313)
(Decrease) increase in accrued expenses and other liabilities	(745)	7,722
Net cash provided by operating activities	37,471	25,109
Cash flows from investing activities:
Net decrease in loans receivable	142,835	135,317
Purchases of loans	(21,674)	(1,529)
Purchases of FHLB of New York stock	(49,678)	(6,381)
Redemptions of FHLB of New York stock	39,854	8,779
Purchases of debt securities available-for-sale	(597,763)	(928,815)
Purchases of equity securities	0	(70)
Proceeds from sale of equity securities	9,261	0
Principal payments and maturities on debt securities available-for-sale	386,619	680,751
Principal payments and maturities on debt securities held-to-maturity	940	186
Purchases and improvements of premises and equipment	(805)	(912)
Net cash used in investing activities	(90,411)	(112,674)
Cash flows from financing activities:
Net decrease in deposits	(164,717)	(2,866)
Dividends paid	(15,944)	(16,462)
Purchase of treasury stock	(15,224)	(18,676)
Decrease in advance payments by borrowers for taxes and insurance	(892)	(2,610)
Proceeds from borrowings and securities sold under agreements to repurchase	4,256,039	455,684
Repayments related to other borrowings and securities sold under agreements to repurchase	(4,042,341)	(324,085)
Net cash provided by financing activities	16,921	90,985
Net (decrease) increase in cash and cash equivalents	(36,019)	3,420
Cash and cash equivalents at beginning of period	167,744	229,506
Cash and cash equivalents at end of period	131,725	232,926
Cash paid during the period for:
Interest	84,945	87,322
Income taxes	9,871	6,178
Non-cash transactions:
Loan charge-offs, net	4,030	4,667
Right-of-use assets obtained in exchange for new lease liabilities	753	2,227
Transfer of loans held-for-sale at fair value to loans held-for-investment	$ 0	$ 4,897